Broncaspin
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
A paediatric suspension of Broncaspin was administered to 32 children aged 2-12 yr hospitalised for acute respiratory infection…
Broncaspin (guacetisal) has been administered rectally to 42 children suffering from inflammatory diseases of the upper and lower…
The therapeutic effectiveness of a new antiinflammatory-expectorant drug, guacetisal (Broncaspin) has been compared with that of…
A controlled single-blind clinical trial was made with Broncaspin, on original synthetic molecule obtained by condensing…
A Broncaspin suspension was administered for an average of 6-7 days (1/2 teaspoonful twice a day to patients up to 3 yr old; 1…
A single-blind, between-patients trial was run on two randomly formed groups of 15 hospitalised male patients with chronic…
The new preparation Broncaspin (guacetisal) has been experimented in the form of 1.2 g suppositories and 5% suspension, in 40…
Controlled clinical research has been carried out on the activity and tolerance of a new active principle, guacetisal (Broncaspin…
The results of an approximately 14-day treatment with 500 mg broncaspin capsules in 25 patients with recrudescent chronic…
An open clinical trial was run on the therapeutic efficacy of a new balsamic-antiinflammatory molecule, guacetisal (presented as…